Syneos Health, Inc.
Syneos Health, Inc. (SYNH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SYNH · as of Jun 9, 2026
Key Statistics
Explore Syneos Health, Inc. Data
synh stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 24 · Buy rate: 50.0%
The SYNH analyst consensus is Buy, based on ratings from 24 Wall Street analysts over the past 3 months. The average 12-month price target is $72.00, representing +67.52% upside from the current price of $42.98.
Competitors & Peers
synh competitorsSYNH
ALPN
AMED
CBAY
LHCG
MRTXStock Performance
Full HistoryAbout Syneos Health, Inc.
Syneos Health, Inc. is a prominent global provider of outsourced biopharmaceutical services, operating with a vast reach across North America, Europe, the Middle East, Africa, the Asia-Pacific region,…
what is syneos health, inc. · synh stock overview · syneos health, inc. company profile · who is syneos health, inc. ceo · synh NASDAQ · syneos health, inc. headquarters · syneos health, inc. business segments
About Stock Overview & Key Data
Syneos Health, Inc. (SYNH) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Nov 7, 2014. As of the latest trading session, SYNH stock price is $42.98, with a market capitalization of $4.5B. The stock has returned -13.22% over the past 12 months and +18.30% year-to-date.
According to 24 Wall Street analysts, the consensus rating for Syneos Health, Inc. stock is Buy, with an average 12-month price target of $72.00. In fiscal year 2022, Syneos Health, Inc. reported revenue of $5.4B and net income of $266.5M. For detailed data — including Syneos Health, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Syneos Health, Inc. (SYNH) stock price is $42.98. The stock is traded on NASDAQ under the ticker symbol SYNH. The 52-week range is $22.89 – $52.23.